Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart device aims to tame persistent AFib
Disease control Recruiting nowThis study is testing a new device called the VARIPULSE catheter system to treat persistent atrial fibrillation, a type of irregular heartbeat. The device uses pulsed field ablation to isolate specific heart veins and may be combined with a procedure to close off a heart pouch to…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New heart tool aims to simplify AFib treatment
Disease control Recruiting nowThis study tests a new system (VARIPULSE catheter and TRUPULSE generator) with updated software for treating persistent atrial fibrillation, a long-lasting irregular heartbeat. About 50 adults aged 18-75 who have not responded to medication will undergo a heart ablation procedure…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New catheter treatment for irregular heartbeat under Long-Term review
Disease control Recruiting nowThis study is checking the long-term safety and effectiveness of the VARIPULSE catheter, a device already approved by the FDA, for treating people with a type of irregular heartbeat called paroxysmal atrial fibrillation. About 276 participants who have symptoms and haven't respon…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New heart procedure tested against leading device for AFib control
Disease control Recruiting nowThis study tests a new catheter called VARIPULSE against an already approved one, FARAWAVE, for people with persistent atrial fibrillation (a long-lasting irregular heartbeat). About 466 participants will receive one of the two treatments to see which is safer and better at resto…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New heart tool aims to make AFib treatment faster and safer
Disease control Recruiting nowThis study is testing a new system (VARIPULSE catheter and TRUPULSE generator) with updated software to treat atrial fibrillation, a condition where the heart beats irregularly. The goal is to see how well the system works in a real-world setting, measuring procedure times and sa…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New heart procedure aims to zap away atrial fibrillation safely
Disease control Recruiting nowThis study is testing a new device that uses pulsed electric fields to treat paroxysmal atrial fibrillation, a condition where the heart beats irregularly. The procedure aims to isolate the pulmonary veins to restore normal rhythm. Researchers will enroll 440 people who have not …
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
8,000-Patient study monitors Real-World safety of heart rhythm devices
Knowledge-focused Recruiting nowThis observational study will follow 8,000 people with irregular heartbeats (arrhythmias) who are scheduled for a standard catheter ablation procedure using Biosense Webster devices. Researchers will track safety issues and how well the procedure works in everyday hospital practi…
Sponsor: Biosense Webster, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New heart mapping catheter put to the test
Knowledge-focused Recruiting nowThis study is testing a new paddle-shaped catheter designed to map the heart's electrical signals in people with various heart rhythm disorders like atrial fibrillation and ventricular tachycardia. The device has many sensors to create a detailed map of the heart's chambers. The …
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC